Iron Horse Diagnostics, Inc. is a privately held molecular diagnostic company focused on the development and commercialization of novel tests to support the diagnosis and management of amyotrophic lateral sclerosis (ALS), traumatic brain injury (TBI), and other neurological diseases.
Iron Horse has developed and validated assays to measure protein-based signatures of disease. Our first product line will be blood-based and cerebrospinal fluid-based diagnostic tests for ALS. We will also have a biomarker panel to monitor ALS disease progression. Our next product will be a blood-based test for TBI and a biomarker panel to assay neuronal injury using a blood sample. We also expect to use our assays to test the effectiveness of drugs in clinical trials.